Amplify Alternative Harvest ETF (MJ) Dividend Yield, History & Forecast

Amplify Alternative Harvest ETF (MJ) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 2.45% ($0.59 per share annually (TTM)). The most recent ex-dividend date was December 30, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $94M. Review MJ dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

MJ fund composition

MJ holds 9 positions, with 99.9% of assets in its ten largest. It charges an expense ratio of 1.12%, and manages $105.3M.

Top 10 holdings

HoldingWeight
CNBSAmplify Seymour Cannabis ETF49.77%
CRONCronos Group Inc11.35%
TLRYTilray Brands Inc7.21%
SNDLSNDL Inc6.49%
ACBAurora Cannabis Inc6.39%
VFFVillage Farms International Inc6.28%
CGCCanopy Growth Corp6.11%
HITIHigh Tide Inc4.30%
OGIOrganigram Global Inc1.82%
AGPXXInvesco Government & Agency Portfolio 12/31/20310.19%

Sector allocation

Healthcare78.8%Consumer Defensive18.1%Real Estate2.2%Consumer Cyclical0.8%Technology0.6%Financial Services0.3%Cash & Others0.0%

Frequently Asked Questions about Amplify Alternative Harvest ETF (MJ)

What is Amplify Alternative Harvest ETF's dividend yield?
Amplify Alternative Harvest ETF (MJ) pays a current trailing twelve-month dividend yield of 2.45%, which works out to $0.59 per share annually based on the most recent payout schedule.
When does Amplify Alternative Harvest ETF pay distributions?
The most recent ex-dividend date was December 30, 2025. The next scheduled dividend payment date is December 31, 2025.
What does Amplify Alternative Harvest ETF invest in?
The Amplify Alternative Harvest ETF, identified by the ticker MJ, aims to replicate the overall financial performance of the Prime Alternative Harvest Index, before accounting for any associated fees or expenses. The fund accomplishes this by investing in a range of companies within the global cannabis industry, specifically those positioned to capitalize on the growing worldwide trend of legalizing cannabis for both medical and recreational purposes.